Home

Market Capitalization of Aurobindo Pharma Ltd

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

Market Cap

₹ 69533.33 crore

Last updated on: Jan 21, 2025

Key Highlights

  • The Market Cap of Aurobindo Pharma Ltd is ₹ 69533 crore as of 21 Jan 25 .
  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1191 as of 22 Jan 15:30 .
  • The Dividend Payouts of Aurobindo Pharma Ltd changed from ₹ 1.5 on Nov 17, 2021 to ₹ 1.5 on Feb 20, 2024 . This represents a CAGR of 0.00% over 6 years.
Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

Share Price

₹ 1191.2

4.50 (0.38%)

stock direction

Last updated on: Jan 22, 2025

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Jan 20251186.7
20 Jan 20251202.7
17 Jan 20251177.85
16 Jan 20251156.6
15 Jan 20251147.35
14 Jan 20251174.9
13 Jan 20251161.85
10 Jan 20251200.1
09 Jan 20251248.7
08 Jan 20251281.65

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Aurobindo Pharma Ltd

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Aurobindo Pharma Ltd

No data available

No data available

Historical P/E Ratio of Aurobindo Pharma Ltd

No data available

* All values are in %

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Aurobindo Pharma Ltd

No data available

* All values are in

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

Aurobindo Pharma Ltd News Hub

Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit

In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at

Read more

16 Aug 2024

Eugia Pharma Specialities receives USFDA warning for Unit III

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S

Read more

16 Aug 2024

Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter

Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai

Read more

12 Aug 2024

Auro Pharma gets USFDA nod for atrophic vaginitis drug

The approved drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD)

Read more

07 Aug 2024

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Aurobindo Pharma Ltd Market Cap

What is the market cap of Aurobindo Pharma Ltd?

As of January 22, 2025, Aurobindo Pharma Ltd has a market capitalization of ₹69533.33, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aurobindo Pharma Ltd's market capitalization?

Aurobindo Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aurobindo Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aurobindo Pharma Ltd's market capitalization change?

Aurobindo Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions